1. Home
  2. ARMP vs MLP Comparison

ARMP vs MLP Comparison

Compare ARMP & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$7.64

Market Cap

295.5M

Sector

Health Care

ML Signal

HOLD

MLP

Maui Land & Pineapple Company Inc.

HOLD

Current Price

$18.11

Market Cap

343.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
MLP
Founded
N/A
1909
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
295.5M
343.7M
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
ARMP
MLP
Price
$7.64
$18.11
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
60.6K
10.7K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$19,457,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
68.24
52 Week Low
$1.74
$13.84
52 Week High
$14.98
$20.34

Technical Indicators

Market Signals
Indicator
ARMP
MLP
Relative Strength Index (RSI) 41.93 68.49
Support Level $7.22 $16.52
Resistance Level $7.70 $20.34
Average True Range (ATR) 0.68 0.48
MACD 0.06 0.11
Stochastic Oscillator 43.10 96.44

Price Performance

Historical Comparison
ARMP
MLP

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating parent company that owns land and commercial property on the island of Maui, Hawaii. The Company puts its assets into productive use by planning, managing, developing, and selling residential, resort, commercial, agricultural, and industrial real estate. Its segments include land development and sales, which cover land planning, entitlement, development, construction, and sales of land assets; leasing, which generates revenue from real property leasing, license fees and royalties, and includes maintenance of real estate assets, conservation activities, and management of water systems in West and Upcountry Maui; and resort amenities, which include a membership program offering benefits within the Kapalua Resort.

Share on Social Networks: